QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (42) Citing Articles via Google Scholar Google Scholar Articles by Bullens, R. W. M. Articles by Willison, H. J. Search for Related Content PubMed PubMed Citation Articles by Bullens, R. W. M. Articles by Willison, H. J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 15, 2002, 22(16):6876-6884

Complex Gangliosides at the Neuromuscular Junction Are Membrane Receptors for Autoantibodies and Botulinum Neurotoxin But Redundant for Normal Synaptic Function

Roland W. M. Bullens^{1, 2}, Graham M. O'Hanlon³, Eric Wagner³, Peter C. Molenaar², Keiko Furukawa⁴, Koichi Furukawa⁴, Jaap J. Plomp^{1, 2}, and Hugh J. Willison³

Departments of ¹ Neurology and ² Physiology, Leiden University Medical Centre, 2300 RC, Leiden, The Netherlands, ³ University Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, G51 4TF, Scotland, and ⁴ Department of Biochemistry II, Nagoya University School of Medicine, Showa-ku, Nagoya 466-0065, Japan

One specialization of vertebrate presynaptic neuronal membranes is their multifold enrichment in complex gangliosides, suggesting that these sialoglycolipids may play a major functional role in synaptic transmission. We tested this hypothesis directly by studying neuromuscular synapses of mice lacking complex gangliosides attributable to deletion of the gene coding for 1,4 GalNAc-transferase (GM2/GD2 synthase), which catalyzes an early step in ganglioside synthesis. Our studies show that complex gangliosides are surprisingly redundant for regulated neurotransmitter release under normal physiological conditions. In contrast, we show that they are membrane receptors for both the paralytic botulinum neurotoxin type-A and human neuropathy-associated anti-ganglioside autoantibodies that arise through molecular mimicry with microbial structures. These data prove the critical importance of complex gangliosides in mediating pathophysiological events at the neuromuscular synapse.

Key words: complex gangliosides; neuromuscular junction; synaptic transmission; botulinum neurotoxin; anti-ganglioside antibodies; Miller Fisher syndrome; 1,4 GalNAc-transferase

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22166876-09$05.00/0

This article has been cited by other articles:

				J. J. Plomp and H. J. Willison Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction J. Physiol., August 15, 2009; 587(16): 3979 - 3999. [Abstract] [Full Text] [PDF]

				K. Kaida, T. Ariga, and R. K Yu Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review Glycobiology, July 1, 2009; 19(7): 676 - 692. [Abstract] [Full Text] [PDF]

				M. Dong, H. Liu, W. H. Tepp, E. A. Johnson, R. Janz, and E. R. Chapman Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons Mol. Biol. Cell, December 1, 2008; 19(12): 5226 - 5237. [Abstract] [Full Text] [PDF]

				P. H. H. Lopez, G. Zhang, M. A. Bianchet, R. L. Schnaar, and K. A. Sheikh Structural requirements of anti-GD1a antibodies determine their target specificity Brain, July 1, 2008; 131(7): 1926 - 1939. [Abstract] [Full Text] [PDF]

				S. K. Halstead, F. M. P. Zitman, P. D. Humphreys, K. Greenshields, J. J. Verschuuren, B. C. Jacobs, R. P. Rother, J. J. Plomp, and H. J. Willison Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model Brain, May 1, 2008; 131(5): 1197 - 1208. [Abstract] [Full Text] [PDF]

				A. Rummel, T. Eichner, T. Weil, T. Karnath, A. Gutcaits, S. Mahrhold, K. Sandhoff, R. L. Proia, K. R. Acharya, H. Bigalke, et al. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept PNAS, January 2, 2007; 104(1): 359 - 364. [Abstract] [Full Text] [PDF]

				M. Dong, F. Yeh, W. H. Tepp, C. Dean, E. A. Johnson, R. Janz, and E. R. Chapman SV2 Is the Protein Receptor for Botulinum Neurotoxin A Science, April 28, 2006; 312(5773): 592 - 596. [Abstract] [Full Text] [PDF]

				M. R. Pagani, R. C. Reisin, and O. D. Uchitel Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals. J. Neurosci., March 8, 2006; 26(10): 2661 - 2672. [Abstract] [Full Text] [PDF]

				J. A. Goodfellow, T. Bowes, K. Sheikh, M. Odaka, S. K. Halstead, P. D. Humphreys, E. R. Wagner, N. Yuki, K. Furukawa, K. Furukawa, et al. Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy J. Neurosci., February 16, 2005; 25(7): 1620 - 1628. [Abstract] [Full Text] [PDF]

				S. K. Halstead, G. M. O'Hanlon, P. D. Humphreys, D. B. Morrison, B. P. Morgan, A. J. Todd, J. J. Plomp, and H. J. Willison Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy Brain, September 1, 2004; 127(9): 2109 - 2123. [Abstract] [Full Text] [PDF]

				G. Zhang, P. H. H. Lopez, C. Y. Li, N. R. Mehta, J. W. Griffin, R. L. Schnaar, and K. A. Sheikh Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies Brain, May 1, 2004; 127(5): 1085 - 1100. [Abstract] [Full Text] [PDF]

				B. C. Jacobs, G. M. O'Hanlon, R. W. M. Bullens, J. Veitch, J. J. Plomp, and H. J. Willison Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding Brain, October 1, 2003; 126(10): 2220 - 2234. [Abstract] [Full Text] [PDF]

				M. Dong, D. A. Richards, M. C. Goodnough, W. H. Tepp, E. A. Johnson, and E. R. Chapman Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells J. Cell Biol., September 29, 2003; 162(7): 1293 - 1303. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help